Apollomics
Latest round
- Series C
Last raised
- Nov 2020
Total raised
- $232M
Investors
- 4
About Apollomics
Apollomics, Inc.Founded in 2016, Apollomics, Inc. is headquartered in Foster City, US, specializing in the development of cancer therapies.35 mn in February 2023.Apollomics, Inc. specializes in the discovery and development of oncology combination therapies, focusing on leveraging the immune system and targeting specific molecular pathways to inhibit cancer progression.Apollomics generates revenue through partnerships and collaborations in the biotechnology sector, particularly focusing on oncology therapies. The company engages in strategic partnerships with healthcare providers, research institutions, and pharmaceutical companies.In February 2023, Apollomics, Inc.35 mn. Details regarding specific upcoming products or timelines for market entry have not been disclosed.
Who invested in Apollomics
4 investors across 3 rounds
See all investors in Apollomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Apollomics
Who invested in Apollomics?
Apollomics has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Apollomics raised?
Apollomics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Apollomics last raise money?
Apollomics's most recent round on record is a Series C, in Nov 2020.
What does Apollomics do?
Apollomics is a biotechnology company.
Where is Apollomics headquartered?
Apollomics is headquartered in Foster City, US.
Which VCs invest in companies like Apollomics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Apollomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Apollomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.